QCM
CRMD icon

Quantinno Capital Management’s CorMedix CRMD Stock Holding History

Quantinno Capital Management’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.1M Buy
140,038
+15,129
+12% +$120K ﹤0.01% 2475
2026
Q1 		$848K Buy
124,909
+113,619
+1,006% +$840K ﹤0.01% 2296
2025
Q4 		$131K Sell
11,290
-4,966
-31% -$54.9K ﹤0.01% 3106
2025
Q3 		$189K Buy
+16,256
New +$197K ﹤0.01% 2778

Other funds holding CRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Quantinno Capital Management's CRMD Position: Q2 2026 in Review

Quantinno Capital Management increased its CorMedix (CRMD) stake by 12% in Q2 2026, buying an estimated $120K and bringing the position to 140,038 shares worth $1.1M. The position accounts for ﹤0.01% of the portfolio, ranked #2475.

Quantinno Capital Management first reported a position in CRMD in Q3 2025 and has held it in 4 quarters since. 194 funds tracked by Wall St. Rank hold CRMD as of Q2 2026.

  • Quantinno Capital Management held 140,038 shares of CorMedix worth $1.1M as of Q2 2026.
  • Quantinno Capital Management bought 15,129 CorMedix shares in Q2 2026, an estimated $120K.
  • CorMedix made up ﹤0.01% of Quantinno Capital Management's portfolio in Q2 2026, its #2475 holding.
  • Quantinno Capital Management first reported a position in CorMedix in Q3 2025 and has held it in 4 quarters since.
  • 194 funds tracked by Wall St. Rank held CorMedix as of Q2 2026.

Based on Quantinno Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.